{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Although none of the provided abstracts explicitly mention “LINC01452,” the collective body of work on long noncoding RNAs (lncRNAs) in these studies illustrates several mechanisms by which lncRNAs influence tumorigenesis and cancer progression. For instance, oncogenic lncRNAs such as ZFAS1 and PCAT5 have been shown to promote cancer cell proliferation, inhibit apoptosis, and modulate transcriptional programs by interacting with chromatin‐modifying proteins (e.g., EZH2, LSD1/CoREST) as well as key transcription factors involved in androgen receptor signaling."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " Similarly, other lncRNAs like LOC283070 contribute to the acquisition of androgen independence by binding nuclear regulatory proteins and interfering with their tumor‐suppressive effects."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Reviews and systematic analyses further underscore that many lncRNAs in prostate and other cancers act as key regulators of cell cycle control, invasion, metastasis, and therapy resistance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Given that LINC01452 is a long noncoding RNA, it is conceivable—by analogy with these examples—that it may serve a regulatory function in cancer cells. LncRNAs with oncogenic or tumor‐suppressive functions frequently exert their roles by interacting with key proteins, influencing epigenetic regulators, modulating hormone receptor pathways, or participating in competing endogenous RNA networks. Thus, while LINC01452 is not directly characterized in the provided abstracts, insights from these studies suggest that its potential functions might include modulation of cell proliferation, apoptosis, and transcriptional regulation, with possible implications as a diagnostic biomarker or therapeutic target in malignancies."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Fengqi Nie, Xiang Yu, Mingde Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.9611"}], "href": "https://doi.org/10.18632/oncotarget.9611"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27246976"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27246976"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Antti Ylipää, Kati Kivinummi, Annika Kohvakka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-15-0217"}], "href": "https://doi.org/10.1158/0008-5472.CAN-15-0217"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26282172"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26282172"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Ying Zhang, Li-Na Wang, Ya-Ni Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The novel long noncoding RNA LOC283070 is involved in the transition of LNCaP cells into androgen-independent cells via its interaction with PHB2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Asian J Androl (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4103/aja.aja_36_18"}], "href": "https://doi.org/10.4103/aja.aja_36_18"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29956684"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29956684"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Bhavna Malik, Felix Y Feng "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNAs in prostate cancer: overview and clinical implications."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Asian J Androl (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4103/1008-682X.177123"}], "href": "https://doi.org/10.4103/1008-682X.177123"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27072044"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27072044"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Maria A Smolle, Thomas Bauernhofer, Karl Pummer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms18020473"}], "href": "https://doi.org/10.3390/ijms18020473"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28241429"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28241429"}]}]}]}